INARI MEDICAL, INC.

(NARI)
  Report
Delayed Nasdaq  -  04:00 2022-06-29 pm EDT
69.28 USD   -0.12%
06/24BTIG Adjusts Inari Medical's Price Target to $100 from $130, Keeps Buy Rating
MT
06/24INARI MEDICAL, INC.(NASDAQGS : NARI) added to Russell Small Cap Comp Value Index
CI
06/24INARI MEDICAL, INC.(NASDAQGS : NARI) added to Russell 3000E Value Index
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Inari Medical, Inc. is a medical device company. The Company operates through the development and commercialization of invasive mechanical thrombectomy devices to treat thromboembolism in the venous system. Its product offerings consist of two minimally invasive, catheter-based mechanical thrombectomy systems, which are for venous system and the treatment of the two distinct manifestations of venous thromboembolism (VTE), deep vein thrombosis (DVT), and pulmonary embolism (PE). The Company’s products include ClotTriever System, FlowTriever System, FlowSaver, FlowStasis and FlowTriever 2. The ClotTriever system is a mechanical thrombectomy system designed to core, capture and remove large clots from large vessels and is used to treat DVT and its components include ClotTriever Catheter and ClotTriever Sheath. The FlowTriever is a large bore catheter-based aspiration and mechanical thrombectomy system designed to remove large clots from large vessels to treat PE.

Number of employees : 800 people.
Sales per Business
20202021Delta
Mechanical Thrombectomy Devices139.67100%276.98100% +98.31%
USD in Million
Sales per region
20202021Delta
United States139.67100%276.98100% +98.31%
USD in Million
Managers
Name Title Age Since
William Hoffman President, Chief Executive Officer & Director 53 2015
Mitchell Hill Chief Financial Officer 62 2019
Thomas Tu Chief Medical Officer 48 2019
Tara Dunn VP-Clinical Affairs & Market Development - -
Brian Strauss Vice President-Engineering - 2017
Venkat Tummala, Dr. Vice President-Medical Affairs - -
Norman Nie Vice President-Information Technology - 2019
Andrew Hykes Chief Operating Officer 48 2020
Angela Ahmad Secretary & General Counsel - -
John Borrell Vice President-Sales 53 -
Members of the board
Name Title Age Since
Don Milder Chairman 67 2019
Jonathan D. Root, Dr. Independent Director 61 2011
Cynthia L. Lucchese Independent Director 60 2019
Catherine M. Szyman Independent Director 54 2019
Kirk G. Nielsen Independent Director 47 2011
Rebecca Chambers Independent Director 43 2021
Dana George Mead Independent Director 62 2021
Robert Warner Independent Director 54 2022
William Hoffman President, Chief Executive Officer & Director 53 2015
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 53,125,434 45,099,416 84.9% 0 0.0% 84.9%
Shareholders
NameEquities%
Wellington Management Co. LLP 4,626,607 8.71%
Don Milder 3,904,220 7.35%
The Vanguard Group, Inc. 3,435,964 6.47%
Macquarie Investment Management Business Trust 2,911,333 5.48%
AllianceBernstein LP 2,865,100 5.39%
Capital Research & Management Co. (International Investors) 2,838,045 5.34%
Longview Asset Management LLC 2,591,665 4.88%
Gilde Healthcare Partners BV 2,400,612 4.52%
Versant Venture Management LLC 2,298,217 4.33%
Capital Research & Management Co. (World Investors) 1,623,454 3.06%
Brand Portfolio
In partnership withAllbrands.markets
More brands of Inari Medical, Inc.